MWNA
BCAB

Marshall Wace North America’s BIOATLA INC BCAB Stock Holding History

Marshall Wace North America’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$960K Buy
652
+29
+5% +$56.5K ﹤0.01% 935
2021
Q2 		$1.32M Buy
+623
New +$1.41M 0.01% 938
2021
Q1 		– Sell
-618
Closed -$1.05M – 1504
2020
Q4 		$1.05M Buy
+618
New +$1.03M ﹤0.01% 936

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Marshall Wace North America's BCAB Position: Q3 2021 in Review

Marshall Wace North America increased its BIOATLA INC (BCAB) stake by 4.7% in Q3 2021, buying an estimated $56.5K and bringing the position to 652 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

Marshall Wace North America first reported a position in BCAB in Q4 2020 and has held it in 3 quarters since. The position peaked at $1.32M in Q2 2021. 86 funds tracked by Wall St. Rank hold BCAB as of Q3 2021.

  • Marshall Wace North America held 652 shares of BIOATLA INC worth $960K as of Q3 2021.
  • Marshall Wace North America bought 29 BIOATLA INC shares in Q3 2021, an estimated $56.5K.
  • BIOATLA INC made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #935 holding.
  • Marshall Wace North America first reported a position in BIOATLA INC in Q4 2020 and has held it in 3 quarters since.
  • Marshall Wace North America's BIOATLA INC position peaked at $1.32M in Q2 2021.
  • 86 funds tracked by Wall St. Rank held BIOATLA INC as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.